2022. Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care. Bleeding, Thrombosis and Vascular Biology. 1, 1 (Apr. 2022). DOI:https://doi.org/10.4081/btvb.2022.9.